|
|
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
一项评价口服HTMC0435片在晚期胆道癌患者中的有效性和安全性的II期临床试验
[Translation] A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Oral HTMC0435 Tablets in Patients with Advanced Biliary Tract Cancer
主要目的:初步评价HTMC0435片治疗晚期胆道癌患者的有效性,在 II期临床推荐给药剂量(RP2D)下探索初步疗效。
次要目的:评价HTMC0435片治疗晚期胆道癌患者的安全性;考察HTMC0435片在晚期胆道癌患者中的药代动力学(PK)特征。
[Translation] Primary objective: To preliminarily evaluate the effectiveness of HTMC0435 tablets in the treatment of patients with advanced biliary tract cancer and explore the preliminary efficacy at the Phase II clinical recommended dose (RP2D).
Secondary objective: To evaluate the safety of HTMC0435 tablets in the treatment of patients with advanced biliary tract cancer; to investigate the pharmacokinetic (PK) characteristics of HTMC0435 tablets in patients with advanced biliary tract cancer.
一项评价口服HTMC0435片在晚期胰腺癌患者中的有效性和安全性的II期临床试验
[Translation] A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Oral HTMC0435 Tablets in Patients with Advanced Pancreatic Cancer
主要目的:初步评价HTMC0435片治疗晚期胰腺癌患者的有效性,在RP2D剂量下探索初步疗效。
次要目的:评价HTMC0435片治疗晚期胰腺癌患者的安全性;考察HTMC0435片在晚期胰腺癌患者中的药代动力学(PK)特征。
[Translation] Primary purpose: To preliminarily evaluate the effectiveness of HTMC0435 tablets in the treatment of patients with advanced pancreatic cancer and explore the preliminary efficacy at the RP2D dose.
Secondary purpose: To evaluate the safety of HTMC0435 tablets in the treatment of patients with advanced pancreatic cancer; to investigate the pharmacokinetic (PK) characteristics of HTMC0435 tablets in patients with advanced pancreatic cancer.
一项评价口服HTMC0435片联合替莫唑胺在晚期实体瘤患者中的有效性和安全性的II期临床试验
[Translation] A phase II clinical trial evaluating the efficacy and safety of oral HTMC0435 tablets combined with temozolomide in patients with advanced solid tumors
主要目的:评价HTMC0435片联合替莫唑胺在晚期实体瘤患者中的有效性。
次要目的:评价HTMC0435片联合替莫唑胺治疗晚期实体瘤患者的安全性。
[Translation] Primary objective: To evaluate the efficacy of HTMC0435 tablets combined with temozolomide in patients with advanced solid tumors.
Secondary objective: To evaluate the safety of HTMC0435 tablets combined with temozolomide in the treatment of patients with advanced solid tumors.
100 Clinical Results associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.